We form sound and lasting partnerships
Since its foundation, the Panpharma Group has implemented an active partnership policy. In a high number of countries, we have developed lasting relationships with major healthcare operators (pharmaceutical companies, distributors) by concluding a high number of licensing and distribution as well as development and manufacturing agreements. This partnership strategy is a means of enhancing our influence and helping to improve the healthcare offer.
- Acquisitions and in-licensing contracts: Panpharma is seeking to extend its portfolio of injectables worldwide by acquiring products, licences or distribution products.
- Distribution and out-licensing contracts: we offer our partners the opportunity for commercial exploitation of our products in those countries where we are not yet established.
- Contract production: we use our production capacities in Europe to manufacture products on behalf of third-party companies.
- Co-development opportunities: Panpharma is open to co-development projects in its area of expertise.